Page 21 - Layout 1

DIABETES AND
OBESITY

Azziz R. Criteria, prevalence, and phenotypes of polycystic 24. Soto N, Iniguez G, lopez P, larenas G, Mujica v, Rey RA, et
ovary syndrome. Fertil Steril. 2016;106(1):6-15. al. Anti-Mullerian hormone and inhibin b levels as markers of
12. Cooney lG, dokras A. beyond fertility: polycystic ovary syn- premature ovarian aging and transition to menopause in type 1
drome and long-term health. Fertil Steril. 2018;110(5):794-809. diabetes mellitus. Hum Reprod. 2009;24(11):2838-44.
13. Codner E, Escobar-Morreale HF. Clinical review: Hyperandro- 25. Kim C, Cleary PA, Cowie CC, braffett bH, dunn Rl, larkin
genism and polycystic ovary syndrome in women with type 1 ME, et al. Effect of glycemic treatment and microvascular com-
diabetes mellitus. J Clin Endocrinol Metab. 2007;92(4):1209-16. plications on menopause in women with type 1 diabetes in the
diabetes Control and Complications Trial/Epidemiology of
14. Ovalle F, Azziz R. Insulin resistance, polycystic ovary syndrome,
diabetes Interventions and Complications (dCCT/EdIC) co-
and type 2 diabetes mellitus. Fertil Steril. 2002;77(6):1095-105.
hort. diabetes Care. 2014;37(3):701-8.
15. Rotterdam EA-SPCWG. Revised 2003 consensus on diagnostic
26. Nelson lM. Clinical practice. Primary ovarian insufficiency. N
criteria and long-term health risks related to polycystic ovary
Engl J Med. 2009;360(6):606-14.
syndrome. Fertil Steril. 2004;81(1):19-25.
27. li J, Eriksson M, Czene K, Hall P, Rodriguez-Wallberg KA.
16. dunaif A. Insulin resistance and the polycystic ovary syndrome:
Common diseases as determinants of menopausal age. Hum
mechanism and implications for pathogenesis. Endocr Rev.
Reprod. 2016;31(12):2856-64.
1997;18(6):774-800.
28. brand JS, van der Schouw YT, Onland-Moret NC, Sharp SJ,
17. legro RS, brzyski RG, diamond MP, Coutifaris C, Schlaff Wd,
Ong KK, Khaw KT, et al. Age at menopause, reproductive life
Casson P, et al. letrozole versus clomiphene for infertility in span, and type 2 diabetes risk: results from the EPIC-InterAct
the polycystic ovary syndrome. N Engl J Med. 2014;371(2):119-
study. diabetes Care. 2013;36(4):1012-9.
29.
29. Mills Jl, Simpson Jl, driscoll SG, Jovanovic-Peterson l, van
18. Teede HJ, Misso Ml, Costello MF, dokras A, laven J, Moran Allen M, Aarons JH, et al. Incidence of spontaneous abortion
l, et al. Recommendations from the international evidence-
among normal women and insulin-dependent diabetic women
based guideline for the assessment and management of poly- whose pregnancies were identified within 21 days of concep-
cystic ovary syndrome. Clin Endocrinol (Oxf).
tion. N Engl J Med. 1988;319(25):1617-23.
2018;89(3):251-68.
30. Hanson U, Persson b, Thunell S. Relationship between haemo-
19. dorman JS, Steenkiste AR, Foley TP, Strotmeyer ES, burke JP, globin A1C in early type 1 (insulin-dependent) diabetic preg-
Kuller lH, et al. Menopause in type 1 diabetic women: is it pre-
nancy and the occurrence of spontaneous abortion and fetal
mature? diabetes. 2001;50(8):1857-62.
malformation in Sweden. diabetologia. 1990;33(2):100-4.
20. brand JS, Onland-Moret NC, Eijkemans MJ, Tjonneland A,
31. Practice Committee of the American Society for Reproductive
Roswall N, Overvad K, et al. diabetes and onset of natural
M. Evaluation and treatment of recurrent pregnancy loss: a
menopause: results from the European Prospective Investiga-
committee opinion. Fertil Steril. 2012;98(5):1103-11.
tion into Cancer and Nutrition. Hum Reprod. 2015;30(6):1491-
8. 32. Guerin A, Nisenbaum R, Ray JG. Use of maternal GHb con-
centration to estimate the risk of congenital anomalies in the
21. Yarde F, van der Schouw YT, de valk HW, Franx A, Eijkemans
offspring of women with prepregnancy diabetes. diabetes Care.
MJ, Spiering W, et al. Age at menopause in women with type 1
2007;30(7):1920-5.
diabetes mellitus: the OvAdIA study. Hum Reprod.
2015;30(2):441-6. 33. Jonasson JM, brismar K, Sparen P, lambe M, Nyren O, Osten-
son CG, et al. Fertility in women with type 1 diabetes: a popu-
22. Freeman EW, Sammel Md, lin H, Gracia CR. Anti-mullerian lation-based cohort study in Sweden. diabetes Care.
hormone as a predictor of time to menopause in late reproduc-
2007;30(9):2271-6.
tive age women. J Clin Endocrinol Metab. 2012;97(5):1673-80.
23. Kim C, Karvonen-Gutierrez C, Kong S, Arends v, Steffes M,
Jaye Adams, MD, MS, FACOG, practices Reproductive En-
McConnell dS, et al. Antimullerian hormone among women with
docrinology and Infertility at the Fertility Center of San Antonio.
and without type 1 diabetes: the Epidemiology of diabetes In-
terventions and Complications Study and the Michigan bone
Health and Metabolism Study. Fertil Steril. 2016;106(6):1446-52.

visit us at www.bcms.org 21